We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-8.4%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$4.07B
AUM Growth
-$732M
Cap. Flow
-$324M
Cap. Flow %
-7.96%
Top 10 Hldgs %
18.03%
Holding
679
New
46
Increased
261
Reduced
260
Closed
64

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$31.9M
2
MCK icon
McKesson
MCK
+$27.5M
3
PG icon
Procter & Gamble
PG
+$27.1M
4
SBUX icon
Starbucks
SBUX
+$27M
5
NVDA icon
NVIDIA
NVDA
+$21M

Sector Composition

Rank Sector Weight
1 Healthcare 28.72%
2 Financials 13.85%
3 Technology 10.05%
4 Consumer Discretionary 8.55%
5 Consumer Staples 8.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALTR
176
DELISTED
Altera Corp
ALTR
$5.53M 0.14%
110,402
+1,919
+2% +$95.4K
BA icon
177
Boeing
BA
$165B
$5.5M 0.13%
41,963
-1,370
-3% -$190K
VLO icon
178
Valero Energy
VLO
$89.8B
$5.48M 0.13%
91,185
-28,126
-24% -$1.79M
RY icon
179
Royal Bank of Canada
RY
$291B
$5.43M 0.13%
98,723
+5,710
+6% +$325K
HON icon
180
Honeywell
HON
$77.1B
$5.42M 0.13%
63,695
-6,203
-9% -$565K
WDC icon
181
Western Digital
WDC
$179B
$5.42M 0.13%
90,219
-8,739
-9% -$526K
MJN
182
DELISTED
Mead Johnson Nutrition Company
MJN
$5.42M 0.13%
76,913
-7,368
-9% -$606K
CCL icon
183
Carnival Corporation Ltd
CCL
$36.1B
$5.38M 0.13%
108,183
+47
+0% +$2.39K
ANAC
184
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$5.36M 0.13%
+45,500
New +$5.94M
ATHM icon
185
Autohome
ATHM
$2.43B
$5.3M 0.13%
+163,000
New +$5.83M
UTHR icon
186
United Therapeutics
UTHR
$26.3B
$5.26M 0.13%
40,100
-3,900
-9% -$626K
AAL icon
187
American Airlines Group
AAL
$9.58B
$5.26M 0.13%
135,398
-154,616
-53% -$6.35M
MCD icon
188
McDonald's
MCD
$188B
$5.24M 0.13%
53,143
-3,239
-6% -$316K
EWC icon
189
iShares MSCI Canada ETF
EWC
$6.04B
$5.22M 0.13%
227,136
-50,553
-18% -$1.24M
IPG
190
DELISTED
Interpublic Group of Companies
IPG
$5.22M 0.13%
272,731
-53,635
-16% -$1.07M
HOT
191
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
$5.19M 0.13%
78,053
-11,780
-13% -$896K
IYR icon
192
iShares US Real Estate ETF
IYR
$4.59B
$5.17M 0.13%
72,900
-429,175
-85% -$31.3M
HAS icon
193
Hasbro
HAS
$12.6B
$5.11M 0.13%
70,837
+31,523
+80% +$2.43M
BABA icon
194
Alibaba
BABA
$269B
$5.08M 0.12%
86,148
-57,270
-40% -$4.16M
AVOL
195
DELISTED
AVOLON HLDGS LTD SHS (CYM)
AVOL
$5.04M 0.12%
+165,642
New +$4.63M
BF.B icon
196
Brown-Forman Class B
BF.B
$12B
$5.04M 0.12%
162,500
+146,875
+940% +$4.79M
FLR icon
197
Fluor
FLR
$7.29B
$5.03M 0.12%
118,803
+114,599
+2,726% +$5.38M
ALNY icon
198
Alnylam Pharmaceuticals
ALNY
$36.3B
$5.01M 0.12%
62,400
-26,600
-30% -$2.96M
MDLZ icon
199
Mondelez International
MDLZ
$77.7B
$4.98M 0.12%
118,941
+84,897
+249% +$3.66M
IMVP
200
Invesco India ETF
IMVP
$122M
$4.96M 0.12%
250,000
-3,000
-1% -$61.9K

Similar funds

Candriam SCA's Q3 2015 Portfolio in Review

As of Q3 2015, Candriam SCA held 679 positions worth $4.07B, down 15% from $4.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Candriam SCA withdrew a net $324M in Q3 2015, closing 64 positions and reducing 260 holdings. Its most notable exit was Alphabet (Google) Class C, an estimated $109M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 29% a quarter earlier, followed by Financials and Technology.

Against the trend, Candriam SCA opened a new position in Masco worth $14.9M.

  • Candriam SCA's largest Q3 2015 buy was Masco: 593,671 shares worth $14.9M.
  • Candriam SCA added most to Nike in Q3 2015, an estimated $31.9M increase.
  • Candriam SCA's biggest Q3 2015 reduction was iShares US Real Estate ETF, cutting an estimated $31.3M.
  • Candriam SCA fully exited Alphabet (Google) Class C in Q3 2015, selling an estimated $109M.
  • Candriam SCA's ten largest holdings make up 18% of its $4.07B portfolio in Q3 2015.
  • Candriam SCA opened 46 new positions and closed 64 in Q3 2015.
  • Candriam SCA's portfolio value fell 15% quarter-over-quarter to $4.07B.

Based on Candriam SCA's 13F filing for Q3 2015, filed 19 Oct 2015.